ACTIV.A.C.™ Therapy System with iOn PROGRESS™ Remote Therapy Monitoring and Care Network

Products described on this website (and associated product information), may not be available for sale in all markets as a result of local regulatory requirements. For information regarding product availability in your market, please contact your local Acelity/KCI representative here.

iOn PROGRESS™ Remote Therapy Monitoring Delivers At-Home Monitoring Services.

Behind every wound is a person trying to find their normal again. The iOn PROGRESS™ Remote Therapy Monitoring System remotely transmits usage data from a cellular-enabled ACTIV.A.C.™ Therapy System directly to KCI's iOn PROGRESS™ Care Network to shed light on the nonclinical elements that might inhibit at-home adherence to prescribed negative pressure wound therapy (NPWT).

The iOn PROGRESS™ Care Network engages with patients, where necessary, with education, coaching, collaboration with caregivers, and support from KCI to help patients get back to their life as usual.


  • Overview
  • How it works
  • Indication & Applications
  • Evidence & Outcomes
  • For Your Patients
  • Eligibility


Your ACTIV.A.C.™ Therapy System with iOn PROGRESS™ Remote Therapy Monitoring:

  • Monitors patients' NPWT adherence in their homes using a cellular-enabled module attached ACTIV.A.C.™ Therapy System

  • Securely transmits data related to the unit and usage directly to KCI

  • Data is reviewed by our team of Virtual Therapy Specialists at the iOn PROGRESS™ Care Network

  • Specialists engage patients, gaining greater insight into their needs, goals and challenges


How it Works


The Proven Power of ACTIV.A.C.™ Therapy, Now with a Built-In Support Network

Patient Enrollment

1. Patients prescribed ACTIV.A.C.™ Therapy at home are deemed eligible by their insurance provider

2. At the start of therapy, the patient is assigned a Virtual Therapy Specialist (VTS) to monitor therapy adherence as a trained wound care resource and an expert in V.A.C.® Therapy

3. The VTS initiates the program by conducting a welcome call with the patient to enroll him or her in the program

4. A patient will work with the same VTS throughout his or her use of NPWT

Monitoring & Engagement

1. Once therapy begins, data about device usage is transmitted from the ACTIV.A.C.™ Therapy System to the VTS through a HIPAA-compliant secure connection

2. If the VTS notices irregularities or lapses in device usage, he or she can call the patient to determine what challenges are prohibiting proper therapy adherence

3. The VTS attempts to understand the root causes, provide troubleshooting, help, edcuation coaching or other communication to get the patient back on track

4. Throughout therapy, the VTS remains an active resource helping the patient take control of his or her healing journey


In the event a problem cannot be solved with a patient directly, the VTS will escalate to the patient's primary clinical provider. While insight and advice may be provided by the VTS, any decision regarding patient care is redirected by the clinician.

Indications & Applications

Before use, physicians should review complete risk information and essential prescribing information which can be found in theInstructions for Use

The V.A.C.® Therapy System is an integrated wound management system for use in acute, extended and home care settings. It is intended to create an environment that promotes wound healing by secondary or tertiary (delayed primary) intention by preparing the wound bed for closure, reducing edema, promoting granulation tissue formation and perfusion, and by removing exudate and infectious material. It is indicated for patients with chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, ulcers (such as diabetic, venous insufficiency or pressure), flaps and grafts.

When used on closed surgical incisions, it is intended to manage the environment of surgical incisions that continue to drain following sutured or staple closure by maintaining a closed environment and removing exudates via the application of NPWT.

Note: Indications apply to the V.A.C.® Therapy System unit only and do not apply to iOn PROGRESS™ Remote Therapy Monitoring.

Evidence & Outcomes

The V.A.C.® Therapy unit has the largest body of evidence to date including over 1,400 peer-reviewed articles, 48 of which are randomized controlled trials (RCTs). These studies have demonstrated the positive clinical outcomes of NPWT, as well as the effectiveness of V.A.C.® Therapy in managing chronic wounds (e.g., pressure ulcers and lower extremity ulcers) and a variety of acute wounds. Some of these studies are listed below.


Note: The above does not apply to iOn PROGRESS™ Remote Therapy Monitoring, only to the V.A.C.® Therapy System.

iOn PROGRESS™ Remote Therapy Monitoring Evidence


Clinical Evidence

Additional summary of evidence and outcomes.
TITLE Evaluating the impact of a patient-centered remote monitoring program on adherence to negative pressure wound therapy
View Abstract on PubMed
STUDY TYPE All levels
DATE 2018
AUTHORS Griffin, et al.
TITLE A patient-centered remote therapy monitoring program focusing on increased adherence to wound therapy: a large cohort study
View Abstract on PubMed
STUDY TYPE All levels
DATE 2018
AUTHORS Griffin, et al.

For Your Patients

The addition of the iOn PROGRESS™ Remote Therapy Monitoring System and Care Network requires minimal additional effort for the patient while providing a constant resource on his or her healing journey.

  • Adds only 0.2 lbs to the overall unit weight, not requiring an additional system to manage
  • Accesses data within the device, requiring no additional tracking for the patient
  • Data is transferred through HIPAA-compliant secure connection, minimizing privacy concerns regarding health data
  • Patient works with the same VTS throughout the course of therapy



KCI is a contracted provider for NPWT with more than 500 Health Insurance Plans in the U.S.


  • iOn PROGRESS™ Remote Therapy Monoting is available to patients based on their health insurance coverage and geography
  • At the time of ordering, your patient will be notified by KCI if he or she is eligible
  • KCI is working aggressively to increase availability